Pharmacokinetic/Pharmacodynamic Modeling in Drug Research and Development-Reference-Cited by-同舟云学术

Pharmacokinetic/Pharmacodynamic Modeling in Drug Research and Development

Published:2000-12 Issue:12 Volume:40 Page:1399-1418
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Derendorf Hartmut¹,Lesko Lawrence J.²,Chaikin Philip³,Colburn Wayne A.⁴,Lee Peter²,Miller Raymond⁵,Powell Robert⁵,Rhodes Gerald³,Stanski Donald⁶,Venitz Jürgen⁷

Affiliation:

1. Department of Pharmaceutics, University of Florida, Gainesville

2. Center for Drug Evaluation and Research, Food and Drug Administration (FDA), Rockville, Maryland

3. Rhone Poulenc, Collegeville, Pennsylvania

4. MDS Harris, Phoenix, Arizona

5. Warner Lambert, Ann Arbor, Michigan

6. Pharsight, Mountain View, California

7. Virginia Commonwealth University, Richmond

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/009127000004001211

Reference69 articles.

1. Kinetics of drug action: An overview

2. Kinetics of pharmacologic response

3. ICH, Guideline E4: Dose‐response information to support drug registration;Federal Register,1994

4. Drugs and Endogenous Ligands Compete for Receptor Occupancy

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Pharmacokinetic-pharmacodynamic model of drugs and their pharmacokinetic differences between normal and disease states;Frontiers in Pharmacology;2024-08-05

2. Accelerated Development of Pharmaceuticals Past, Present, and Future;Pharmaceutical Research;2024-08

3. DeLA-DrugSelf: Empowering multi-objective de novo design through SELFIES molecular representation;Computers in Biology and Medicine;2024-06

4. Insights into pharmacokinetic properties for exposure chemicals: predictive modelling of human plasma fraction unbound (f_u) and hepatocyte intrinsic clearance (Cl_int) data using machine learning;Digital Discovery;2024

5. Unveiling the antiviral activity of 2′,3,5,7-Tetrahydroxyflavanone as potential inhibitor of chikungunya virus envelope glycoprotein;Informatics in Medicine Unlocked;2024